Cy Stein, M.D., Ph.D., joined City of Hope as the new chair of the Department of Medical Oncology & Therapeutics Research on March 6. An accomplished oncologist specializing in the biology and treatment of genitourinary cancers, Stein will oversee the department’s clinical and research programs.
Cy Stein (Photo by p.cunningham)
“Dr. Stein is nationally recognized for his excellence as a physician, scientist, mentor and collaborator,” said Alexandra Levine, M.D., M.A.C.P., City of Hope’s chief medical officer. “It is my pleasure to welcome him to the City of Hope family and I look forward to his contributions, which will further the growth and excellence of our medical oncology programs.”
Before joining City of Hope, Stein served as director of medical genitourinary oncology and professor of medicine in urology and molecular pharmacology at the Montefiore Einstein Cancer Center in New York. Prior to
this, he served as assistant professor of medicine at Columbia University’s College of Physicians and Surgeons and as a senior staff fellow and clinical associate at the National Cancer Institute in Bethesda, Md. He has received a Clinical Career Development Award from the American Cancer Society.
Stein currently is co-editor-in-chief of Nucleic Acid Therapeutics and the series editor for Perspectives in Antisense Science. He also has served on the editorial advisory boards for Cancer Gene Therapy, Clinical Cancer Research and other publications. His papers and opinions have been published
in numerous prominent journals, including Science, Nature Biotechnology and Annals of Internal Medicine.
Stein has been named a top physician in his field by New York Times Magazine and New York Magazine, and he has been awarded 11 patents.
He completed his internship and residency in internal medicine at the New York Hospital-Cornell Medical Center and received his doctor of medicine degree from the Albert Einstein College of Medicine and his doctor of philosophy degree in organic chemistry from Stanford University.